140 related articles for article (PubMed ID: 27997807)
21. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms.
Manetsch M; Ramsay EE; King EM; Seidel P; Che W; Ge Q; Hibbs DE; Newton R; Ammit AJ
Br J Pharmacol; 2012 Aug; 166(7):2049-59. PubMed ID: 22372570
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2020; 15():125-134. PubMed ID: 32021151
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1.
Quante T; Ng YC; Ramsay EE; Henness S; Allen JC; Parmentier J; Ge Q; Ammit AJ
Am J Respir Cell Mol Biol; 2008 Aug; 39(2):208-17. PubMed ID: 18314542
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of long-acting β
Kim Y; Hou V; Huff RD; Aguiar JA; Revill S; Tiessen N; Cao Q; Miller MS; Inman MD; Ask K; Doxey AC; Hirota JA
Respir Res; 2021 Oct; 22(1):266. PubMed ID: 34666750
[TBL] [Abstract][Full Text] [Related]
27. Impact of the cAMP efflux and extracellular cAMP-adenosine pathway on airway smooth muscle relaxation induced by formoterol and phosphodiesterase inhibitors.
Satori NA; Pacini ESA; Godinho RO
Chem Biol Interact; 2023 Sep; 382():110630. PubMed ID: 37442289
[TBL] [Abstract][Full Text] [Related]
28. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
29. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro.
Burgess JK; Oliver BG; Poniris MH; Ge Q; Boustany S; Cox N; Moir LM; Johnson PR; Black JL
J Allergy Clin Immunol; 2006 Sep; 118(3):649-57. PubMed ID: 16950284
[TBL] [Abstract][Full Text] [Related]
30. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro.
Milara J; Peiró T; Serrano A; Artigues E; Aparicio J; Tenor H; Sanz C; Cortijo J
COPD; 2015 Jun; 12(3):320-31. PubMed ID: 25207459
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of NOX4 expression by roflumilast N-oxide reduces markers of fibrosis in lung fibroblasts.
Vecchio D; Acquaviva A; Arezzini B; Tenor H; Martorana PA; Gardi C
Mediators Inflamm; 2013; 2013():745984. PubMed ID: 24027357
[TBL] [Abstract][Full Text] [Related]
32. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
33. β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers.
Niimi K; Ge Q; Moir LM; Ammit AJ; Trian T; Burgess JK; Black JL; Oliver BG
Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L334-42. PubMed ID: 22101762
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
35. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.
Kaur M; Holden NS; Wilson SM; Sukkar MB; Chung KF; Barnes PJ; Newton R; Giembycz MA
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L505-14. PubMed ID: 18586957
[TBL] [Abstract][Full Text] [Related]
36. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis.
Joshi R; Yan D; Hamed O; Mostafa MM; Joshi T; Newton R; Giembycz MA
Mol Pharmacol; 2019 Jul; 96(1):56-72. PubMed ID: 31036559
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1.
Che W; Parmentier J; Seidel P; Manetsch M; Ramsay EE; Alkhouri H; Ge Q; Armour CL; Ammit AJ
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):358-68. PubMed ID: 24032470
[TBL] [Abstract][Full Text] [Related]
38. Long-acting β
Altonsy MO; Mostafa MM; Gerber AN; Newton R
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L358-L370. PubMed ID: 28039105
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure.
Nino G; Hu A; Grunstein JS; Grunstein MM
J Allergy Clin Immunol; 2010 May; 125(5):1020-7. PubMed ID: 20392484
[TBL] [Abstract][Full Text] [Related]
40. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]